This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Giant Axonal Neuropathy 1
Information about Giant Axonal Neuropathy 1: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Giant Axonal Neuropathy 1
Most recent studies have shown that Giant Axonal Neuropathy 1 shares some biological mechanisms with ataxia, atrophy, cns-disorder, demyelinating-diseases, demyelination, dystrophy, hereditary-motor-and-sensory-neuropathies, muscular-atrophy, nerve-degeneration, nervous-system-disorder, nervousness, neuroaxonal-dystrophies, neurodegenerative-disorders, nystagmus, peripheral-neuropathy, polyneuropathy, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Giant Axonal Neuropathy 1, and have been seen in publications frequently: Aging, Axon Guidance, Cell Cycle, Cell Death, Cell Proliferation, Gene Silencing, Innervation, Intermediate Filament Organization, Intestinal Absorption, Localization, Microtubule Depolymerization, Muscle Atrophy, Neurogenesis, Pathogenesis, Reflex, Regeneration, Short-term Memory, Transport, Tropism
Quite a number of genes have been found to play important roles in Giant Axonal Neuropathy 1, such as ANPEP, DES, GAN, GFAP, IGFALS, MAP1A, MAP1B, MAP1S, MTSS1, NFASC, PANK2, SOD1, TBCB, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.